• 1
    Bus SA, Valk GD, van Deursen RW, et al. The effectiveness of footwear and offloading interventions to prevent and heal foot ulcers and reduce plantar pressure in diabetes: a systematic review. Diabetes Metab Res Rev 2008; 24(Suppl 1): S162180.
  • 2
    Lipsky BA. New developments in diagnosing and treating diabetic foot infections. Diabetes Metab Res Rev 2008; 24(Suppl1): S6671.
  • 3
    Hinchliffe RJ, Valk GD, Apelqvist J, et al. A systematic review of the effectiveness of interventions to enhance the healing of chronic ulcers of the foot in diabetes. Diabetes Metab Res Rev 2008; 24(Suppl 1): S119144.
  • 4
    Scottish Intercollegiate Guidelines Network 50: A guideline developer's handbook. Accessed 6th February 2011.
  • 5
    Paul AG, Ahmad NW, Ariff AM, Saranum M, Naicker AS, Osman Z. Maggot debridement therapy with Lucillia cuprina: a comparison with conventional debridement in diabetic foot ulcers. Int Wound J 2009; 6: 3946.
  • 6
    Caputo WJ, Beggs DJ, DeFede JL, Simm L, Dharma H. A prospective randomised controlled trial comparing hydrosurgery debridement with conventional surgical debridement in lower extremity ulcers. Int Wound J 2008; 5: 288294.
  • 7
    Jeffcoate WJ, Price PE, Phillips CJ, et al. Randomised controlled trial of the use of three dressing preparations in the management of chronic ulceration of the foot in diabetes. Health Technol Assess 2009; 13: 186.
  • 8
    Jude EB, Apelqvist J, Spraul M, Martini J. Prospective randomized controlled study of Hydrofiber dressing containing ionic silver or calcium alginate dressings in non-ischaemic diabetic foot ulcers. Diabet Med 2007; 24: 280288.
  • 9
    Jacobs AM, Tomczak R. Evaluation of Bensal HP for the treatment of diabetic foot ulcers. Adv Skin Wound Care 2008; 21: 461465.
  • 10
    Krause FG, de Vries G, Meakin C, Kalia TP, Younger AS. Outcome of transmetatarsal amputations in diabetics using antibiotic beads. Foot Ankle Int 2009; 30: 486493.
  • 11
    Shukrimi A, Sulaiman AR, Halim AY, Azril A. A comparative study between honey and povidone iodine as dressing solution for Wagner type II diabetic foot ulcers. Med J Malaysia 2008; 63: 4446.
  • 12
    Piaggesi A, Goretti C, Mazzurco S, et al. A randomized controlled trial to examine the efficacy and safety of a new super-oxidized solution for the management of wide postsurgical lesions of the diabetic foot. Int J Low Extrem Wounds 2010; 9: 1015.
  • 13
    Piaggesi A, Schipani E, Campi F, et al. Conservative surgical approach versus non-surgical management for diabetic neuropathic foot ulcers: a randomized trial. Diabet Med 1998; 15: 412417.
  • 14
    Abidia A, Laden G, Kuhan G, et al. The role of hyperbaric oxygen therapy in ischaemic diabetic lower extremity ulcers: a double-blind randomised-controlled trial. Eur J Vasc Endovasc Surg 2004; 27: 513518.
  • 15
    Chen CE, Ko JY, Fong CY, Juhn RJ. Treatment of diabetic foot infection with hyperbaric oxygen. Int J Low Wounds 2010; 9: 1015.
  • 16
    Duzgun AP, Satir HZ, Ozozan O, Saylam B, Kulah B, Coskun F. Effect of oxygen therapy on healing of diabetic foot ulcers. J Foot Ankl Surg 2008; 47: 515519.
  • 17
    Löndahl M, Katzman P, Nilsson A, Hammarlund C. Hyperbaric oxygen therapy facilitates healing of chronic foot ulcers in patients with diabetes. Diabetes Care 2010; 33: 9981003.
  • 18
    Lipsky BA, Berendt AR. Hyperbaric oxygen therapy for diabetic foot wounds: has hope hurdled hype? Diabetes Care 2010; 33: 11431145.
  • 19
    Akbari A, Moodi H, Ghiasi F, Sagheb HM, Rashidi H. Effects of vacuum-compression therapy on healing of diabetic foot ulcers: randomized controlled trial. J Rehabil Res Dev 2007; 44: 631636.
  • 20
    Kavros SJ, Konstantinos TD, Turner NS, et al. Improving limb salvage in critical ischaemia with intermittent pneumatic compression: a controlled study with 18 month follow-up. J Vasc Surg 2008; 47: 543549.
  • 21
    Mars M, Desai Y, Gregory MA. Compressed air massage hastens healing of the diabetic foot. Diabetes Technol Ther 2008; 10: 3945.
  • 22
    Sepulveda G, Espindola M, Maureira A, et al. Negative-pressure wound therapy versus standard wound dressing in the treatment of diabetic foot amputation. A randomised controlled trial. Cirurg Espanola 2009; 86: 171177.
  • 23
    Blume PA, Walters J, Payne W, Ayala J, Lantis J. Comparison of negative pressure wound therapy using vacuum-assisted closure with advanced moist wound therapy in the treatment of diabetic foot ulcers. Diabetes Care 2008; 31: 631636.
  • 24
    Frykberg RG, Williams DV. Negative-pressure wound therapy and diabetic foot amputations. J Am Podiatr Assoc 2007; 97: 351359.
  • 25
    Cruciani M, Lipsky BA, Mengoli C, de Lalla F. Granulocyte-colony stimulating factors as adjunctive therapy for diabetic foot infections. Diabetes Care 2005; 28: 454460.
  • 26
    Viswanathan V, Pendsey S, Sekar N, Murthy GSR. A phase II study to evaluate the safety and efficacy of recombinant human epidermal growth factor (REGEN-D ™ 150) in healing diabetic foot ulcers. Wounds 2006; 18: 186196.
  • 27
    Fernandez-Montequin JI, Valenzuela-Silva CM, Diaz OG, et al. Intra-lesional injections of recombinant human epidermal growth factor promote granulation and healing in advanced diabetic foot ulcers: multicenter, randomised, placebo-controlled, double-blind study. Int Wound J 2009; 6: 432443.
  • 28
    Uchi H, Igarashi A, Urabe K, et al. Clinical efficacy of basic fibroblast growth factor (bFGF) for diabetic ulcer. Eur J Dermatol 2009; 19: 461468.
  • 29
    Richard JL, Parer-Richard C, Daures JP, et al. Effect of fibroblast growth factor on the healing of chronic diabetic neuropathic ulcer of the foot. A pilot, randomized, double-blind, placebo-controlled study. Diabetes Care 1995; 18: 6469.
  • 30
    Kusumanto YH, Van Weel V, Mulder NH, et al. Treatment with intramuscular vascular endothelial growth factor gene compared with placebo for patients with diabetes mellitus and critical limb ischaemia: a double-blind randomized trial. Human Gene her 2006; 17: 683691.
  • 31
    Lázaro-Martínez JL, García-Morales E, Beneit-Montesinos JV, Martínez-de-Jesis FR, Aragón-Sánchez FJ. Randomized comparative trial of a collagen/oxidized regenerated cellulose dressing in the treatment of neuropathic diabetic foot ulcers. Cirurg Espanola 2007; 82: 2731.
  • 32
    Kakagia DD, Kazakos KJ, Xarchas KC, et al. Synergistic action of protease-modulating matrix and autologous growth factors in healing of diabetic foto ulcers. A prospective randomized trial. J Diabetes Complications 2007; 21: 387391.
  • 33
    Lyons TE, Miller MS, Serena T, et al. Talactoferrin alfa, a recombinant human lactoferrin promotes healing of diabetic neuropathic ulcers: a phase 1/2 clinical study. Am J Surg 2007; 193: 4954.
  • 34
    Brigido SA. The use of an acellular dermal regenerative matrix in the treatment of lower extremity wounds: a prospective 16-week pilot study. Int Wound J 2006; 3: 161167.
  • 35
    Reyzelman A, Crews RT, Moore L, et al. Clinical effectiveness of an acellular dermal regenerative tissue matrix compared to standard wound management in healing diabetic foot ulcers: a prospective, randomised, multicentre study. Int Wound J 2009; 6: 196208.
  • 36
    Fife C, Mader JT, Stone J, et al. Thrombin peptide Chrysalin stimulates healing of diabetic foot ulcers in a placebo-controlled phase I/II study. Wound Repair Regen 2007; 15: 2334.
  • 37
    Purandare H, Supe A. Immunomodulatory role of Tinospora cordifolia as an adjuvant in surgical treatment of diabetic foot ulcers: a prospective randomized controlled study. Indian J Med Sci 2007; 61: 347355.
  • 38
    Jeong S-H, Han S-K, Kim W-K. Treatment of diabetic foot ulcers using a blood bank concentrate. Plast Reconstr Surg 2010; 125: 944952.
  • 39
    Seung-Kyu H, Hyon-Surk K, Woo-Kyung K. Efficacy and safety of fresh fibroblast allografts in the treatment of diabetic foot ulcers. Dermatol Surg 2009; 35: 13421348.
  • 40
    Seung-Kyu H, Hong-Ryul K, Woo-Kyung K. The treatment of diabetic foot ulcers with uncultured, processed lipoaspirate cells: a pilot study. Wound Rep Reg 2010; 18: 342346.
  • 41
    Edmonds M. Apligraf in the treatment of neuropathic diabetic foot ulcers. Int J Low Extrem Wounds 2009; 8: 1118.
  • 42
    Moustafa M, Bullock AJ, Creagh FM, et al. Randomized, controlled, single-blind study on use of autologous keratinocytes on a transfer dressing to treat nonhealing ulcers. Regen Med 2007; 2: 887902.
  • 43
    Mahmoud SM, Mohamed AA, Mahdi SE, Ahmed ME. Split-skin graft in the management of diabetic foot ulcers. J Wound Care 2008; 17: 303306.
  • 44
    Margara A, Boriani F, Obbialero FD, Bocciotti MA. Frequency rhythmic electrical modulation system in the treatment of diabetic ulcers. Chirurgia 2008; 21: 311314.
  • 45
    Petrofsky JS, Lawson D, Berk L, Suh H. Enhanced healing of diabetic foot ulcers using local heat and electrical stimulation for 30 min three times a week. J Diabetes 2010; 2: 4146.
  • 46
    Moretti B, Notamicola A, Maggio G, et al. The management of neuropathic ulcers of the foot in diabetes shock wave therapy. BMC Musculoskelet Disord 2009; 10: 5461.
  • 47
    Wang CJ, Kuo YR, Wu RW, et al. Extracorporeal shockwave treatment for chronic diabetic foot ulcers. J Surg Res 2009; 152: 96103.
  • 48
    Rullan M, Cerdà L, Frontera G, Masmiquel L, Llobera J. Treatment of chronic diabetic foot ulcers with bemiparin: a randomized, triple blind, placebo-controlled, clinical trial. Diabet Med 2008; 25: 10901095.
  • 49
    Sert M, Soydas B, Aikimbaev T, Tetiker T. Effects of iloprost (a prostacyclin analogue) on the endothelial function and foot ulcers in diabetic patients with peripheral arterial disease. Int J Diabetes Metab 2008; 16: 711.
  • 50
    Leung PC, Wong MV, Wong WC. Limb salvage in extensive diabetic foot ulceration: an extended study using a herbal supplement. Hnk Kng Med J 2008; 14: 2933.
  • 51
    Bahrami A, Kamali K, Ali-Asgharzadeh A, et al. Clinical applications of oral form of ANGIPARSTM and in combination with topical form as a new treatment for diabetic foot ulcers: a randomized controlled trial. DARU 2008; 16(Suppl 1): S4148.
  • 52
    Larijani B, Heshmat R, Bahrami A, et al. Effects of intravenous Semelil (ANGIPARS™) on diabetic foot ulcers healing: a multicenter clinical trial. DARU 2008; 16(Suppl 1): S3540.
  • 53
    Edwards J, Stapley S. Debridement of diabetic foot ulcers. Cochrane Syst Rev 2010: Issue 1, Art. No.: CD003556.
  • 54
    NICE clinical guidelines. Diabetic foot problems: inpatient management of diabetic foot problems. Prepublication check http// Accessed 6th February 2011
  • 55
    Karthikesalingam A, Holt PJ, Moxey P, Jones KG, Thompson MM, Hinchliffe RJ. A systematic review of scoring systems for diabetic foot ulcers. Diabet Med 2010; 27: 544549.